Related Experiment Videos
Na+ channel expression along axons in multiple sclerosis and its models
Stephen G Waxman1, Matthew J Craner, Joel A Black
1Department of Neurology and Center for Neuroscience and Regeneration Research, Yale School of Medicine, New Haven, CT 06510, USA. stephen.waxman@yale.edu
Trends in Pharmacological Sciences
|October 20, 2004
Summary
In multiple sclerosis, some axons regain function after myelin loss, aiding remission. Others degenerate, causing permanent disability due to altered sodium channel expression in both models and human tissue.
Area of Science:
- Neuroscience
- Neuroimmunology
- Cellular Biology
Background:
- Multiple sclerosis (MS) involves myelin loss from axons, impacting nerve impulse conduction.
- Axonal damage in MS leads to persistent neurological deficits and disability.
- Some MS patients experience remissions, suggesting potential for functional recovery despite demyelination.
Purpose of the Study:
- To investigate the molecular mechanisms underlying axonal recovery versus degeneration in demyelinating conditions like MS.
- To identify the role of specific sodium (Na+) channel isoforms in axonal function following myelin loss.
- To correlate findings from experimental models with observations in human MS tissue.
Main Methods:
- Utilized laboratory models simulating demyelination and axonal damage.
- Analyzed the expression patterns of distinct sodium channel isoforms in affected axons.
- Examined human multiple sclerosis tissue samples to validate findings from experimental models.
Main Results:
- Identified altered expression of two specific sodium (Na+) channel isoforms correlating with different axonal fates (recovery vs. degeneration).
- Observed that functional recovery of demyelinated axons is associated with specific Na+ channel isoform changes.
- Confirmed similar alterations in Na+ channel expression in human multiple sclerosis tissue, linking them to disease processes.
Conclusions:
- Altered sodium (Na+) channel isoform expression is a key mechanism differentiating axonal recovery from degeneration in multiple sclerosis.
- These molecular changes provide a basis for understanding remission and persistent disability in MS patients.
- Findings highlight potential therapeutic targets for preserving axonal function and mitigating disability in multiple sclerosis.